---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-032099"
form_type: "8-K"
ticker: "CLAR"
cik: "0000913277"
company_name: "Clarus Corp"
filed_at: "2024-03-08T23:59:59+00:00"
generated_at: "2026-06-05T01:01:33.132606+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Clarus permits Greenhouse and Kanders to increase stakes to 15% and 26.7% under poison pill waiver

## Summary
- Greenhouse (current ~11.9% owner) approved to acquire up to 15.0% of CLAR common stock within 12 months.
- Executive Chairman Warren Kanders (current ~16.7%) approved to acquire up to 26.7% within 12 months.
- Waivers terminate if either party's ownership falls below 9.9%; new board approval required to exceed that threshold.
- Approvals are conditioned on not exceeding the stated caps and apply to the 2008 Rights Agreement.

## SEC filing metadata
- accession: 0001104659-24-032099
- form_type: 8-K
- ticker: CLAR
- cik: 0000913277
- company_name: Clarus Corp
- filed_at: 2024-03-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/913277/000110465924032099/0001104659-24-032099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/913277/000110465924032099/tm248174d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-032099
- JSON: https://secwatch.observer/filing/0001104659-24-032099.json
- Plain text: https://secwatch.observer/filing/0001104659-24-032099.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.